Zhang Yu, Huang Wanbin, Pan Songqing, Shan Zhengming, Zhou Yanjie, Gan Quan, Xiao Zheman
Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
Heliyon. 2023 Nov 14;9(11):e22285. doi: 10.1016/j.heliyon.2023.e22285. eCollection 2023 Nov.
Primary headache disorder is the main cause of headache attacks, leading to significant disability and impaired quality of life. This disorder is increasingly recognized as a heterogeneous condition with a complex network of genetic, environmental, and lifestyle factors. However, the timely diagnosis and effective treatment of these headaches remain challenging. Precision medicine is a potential strategy based on P4 (predictive, preventive, personalized, and participatory) medicine that may bring new insights for headache care. Recent machine learning advances and widely available molecular biology and imaging data have increased the usefulness of this medical strategy. Precision medicine emphasizes classifying headaches according to their risk factors, clinical presentation, and therapy responsiveness to provide individualized headache management. Furthermore, early preventive strategies, mainly utilizing predictive tools, are critical in reducing headache attacks and improving the quality of life of individuals with headaches. The current review comprehensively discusses the potential application value of P4 medicine in headache management.
Ont Health Technol Assess Ser. 2010
Curr Treat Options Neurol. 2013-12
Handb Clin Neurol. 2015
Ter Arkh. 2022-1-15
Headache. 2010-2-9
Plast Reconstr Surg. 2023-2-1
Front Pharmacol. 2022-11-18
Lancet Neurol. 2022-10